Malignant mesothelioma: predictors of prognosis and clinical trials.
نویسندگان
چکیده
The Journal Impact Factors for 1999 have recently been released and indicate that Thorax has again increased its impact factor, from 2.861 in 1998 to 3.437 in 1999. Thorax has thus further consolidated its position as the highest ranking specialist respiratory journal after the two American Thoracic Society publications. The position of Thorax in terms of impact factor relative to other selected specialist journals of similar or complementary interest is shown in the table. We are pleased to see this continued improvement in the international status of the journal, and thank all who have helped to achieve it. The ultimate determinant of the impact factor of the journal is the standard of the papers submitted to us. Thank you to all who have sent us their work. Please send us more!
منابع مشابه
The Economic Impact of Clinical Research in an Italian Public Hospital: The Malignant Pleural Mesothelioma Case Study
Background The current economic constraints cause hospital management to use the available public resources as rationally as possible. At the same time, there is the necessity to improve current scientific knowledge. This is even more relevant in the case of patients with malignant pleural mesothelioma (MPM), given the severity of the disease, its dismal prognosis, and the cost of chemotherapy ...
متن کاملگزارش یک مورد مزوتلیوم بدخیم تونیکا واژینالیس بیضه
Malignant mesothelioma of the tunica vaginalis constitutes a very rare but often fatal malignancy of the male genitalia. This diagnosis should be suspected in patients exposed to asbestos and those presenting with clinical symptoms of either hydrocele or inguinal hernia. We report here a case of malignant mesothelioma of the tunica vaginalis. A 69-year-old man with a left hydrocele and inguina...
متن کاملDiffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research.
Diffuse malignant peritoneal mesothelioma (DMPM) is an uncommon and locally aggressive tumor with poor prognosis. Currently, no standard therapy is available. The biology of this disease is still poorly understood. We performed a systematic search of relevant studies on clinical management and biological research of DMPM. Trials were selected using a predetermined protocol. The current evidence...
متن کاملThe Role of Inflammation in Development and Therapy of Malignant Mesothelioma
Malignant Mesothelioma (MM) is an asbestos related malignancy with a poor prognosis and limited therapeutic approaches. The pathogenesis of MM has been linked to asbestos induced inflammation. Asbestos exposure results in reactive oxygen species generation, infiltration of inflammatory cells and prolonged release of multiple cytokines, oxidants and growth factors. The role of inflammation in MM...
متن کاملThe Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion
Background and Objective: Early diagnosis of malignant pleural mesothelioma (MPM) is the key point of its treatment. The main problem is the precise diagnosis of mesothelioma and its differentiation from metastatic lung adenocarcinoma. Mesothelioma exhibits complex immunohistochemical characteristics. The aim of this study was to study hybrid immunohistochemistry in the differe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Thorax
دوره 55 9 شماره
صفحات -
تاریخ انتشار 2000